Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Sábháilte in:

Sonraí bibleagrafaíochta
Foilsithe in:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Príomhchruthaitheoir:	Khan, Mohd Shahnawaz
Rannpháirtithe:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Foilsithe / Cruthaithe:	Nature Publishing Group
Ábhair:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Rochtain ar líne:	Citation/Abstract Full Text Full Text - PDF
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Bí ar an gcéad duine le trácht a dhéanamh!